-
Something wrong with this record ?
Inflammatory biomarkers and liver histopathology in non-uremic and uremic chronic hepatitis C patients
B. Tatar, S. Kose, E. Pala, E. Tatar
Language English Country Czech Republic
Document type Journal Article
Digital library NLK
Volume
Source
NLK
Directory of Open Access Journals
from 1997
Free Medical Journals
from 1997
Open Access Digital Library
from 1997-01-01
Medline Complete (EBSCOhost)
from 2012-06-01
ROAD: Directory of Open Access Scholarly Resources
from 1997
- MeSH
- Biomarkers metabolism MeSH
- Biopsy MeSH
- Hepatitis C, Chronic physiopathology MeSH
- Adult MeSH
- Liver pathology MeSH
- Middle Aged MeSH
- Humans MeSH
- Neutrophils metabolism MeSH
- Leukocyte Count MeSH
- Lymphocyte Count MeSH
- Chitinase-3-Like Protein 1 blood MeSH
- Aged MeSH
- Case-Control Studies MeSH
- Severity of Illness Index MeSH
- Blood Platelets metabolism MeSH
- Uremia complications MeSH
- Inflammation physiopathology MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
BACKGROUND: The aim of this study is to investigate the association between hepatic activity index (HAI) and fibrosis score (FS) with inflammation biomarkers in non-uremic and uremic hepatitis C positive patients. METHODS: Fifty chronic hepatitis C (cHepC) positive patients, having a liver biopsy were included in this study. Liver biopsies were scored according to modified ISHAC scoring system. 25 healthy controls of similar age and gender were also enrolled as control group. Serum YKL-40, neutrophil/lymphocyte ratio (NLR), thrombocyte/lymphocyte ratio (PLR), CRP and Immunoglobulin (IgG, A and M) levels were used to determine inflammation. AST to Platelet Ratio Index (APRI) score was also evaluated. According to biopsy findings patients were divided into 2 groups: low (0-2) and severe (3-6) FS. RESULTS: Patients with cHepC had increased inflammation compared to the healthy controls. End-stage renal disease (ESRD) patients had higher levels of inflammation markers (NLR, IgG, CRP and YKL-40) and lower HCV RNA levels, HAI and FS compared to non-uremic patients. When patients were grouped into 2 according to FS as mild and severe, IgG (p < 0.001), YKL-40 (p = 0.02) levels and APRI score (p = 0.002) were significantly higher compared to mild FS (p = 0.002). YKL-40 levels (t value: 3.48; p = 0.001) and APRI score (t value: 4.57, p < 0.001) were found as independent associated with FS in non-uremic patients. However, in adjusted models, only APRI score (t value: 3.98, p = 0.002) was an independent associated with FS in ESRD patients. CONCLUSION: In non-uremic cHepC patients, YKL-40 levels and APRI score may be valuable markers of FS. In ESRD patients, there is not sufficient data for prediction of HAI and FS. In these patients, APRI score may provide better information.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18021083
- 003
- CZ-PrNML
- 005
- 20180621133822.0
- 007
- ta
- 008
- 180611s2017 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.14712/18059694.2017.96 $2 doi
- 035 __
- $a (PubMed)28976873
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Tatar, Bengu $u University of Health Science, Izmir Tepecik Education and Research Hospital, Clinic of Infectious Diseases and Clinical Microbiology, Izmir, Turkey
- 245 10
- $a Inflammatory biomarkers and liver histopathology in non-uremic and uremic chronic hepatitis C patients / $c B. Tatar, S. Kose, E. Pala, E. Tatar
- 520 9_
- $a BACKGROUND: The aim of this study is to investigate the association between hepatic activity index (HAI) and fibrosis score (FS) with inflammation biomarkers in non-uremic and uremic hepatitis C positive patients. METHODS: Fifty chronic hepatitis C (cHepC) positive patients, having a liver biopsy were included in this study. Liver biopsies were scored according to modified ISHAC scoring system. 25 healthy controls of similar age and gender were also enrolled as control group. Serum YKL-40, neutrophil/lymphocyte ratio (NLR), thrombocyte/lymphocyte ratio (PLR), CRP and Immunoglobulin (IgG, A and M) levels were used to determine inflammation. AST to Platelet Ratio Index (APRI) score was also evaluated. According to biopsy findings patients were divided into 2 groups: low (0-2) and severe (3-6) FS. RESULTS: Patients with cHepC had increased inflammation compared to the healthy controls. End-stage renal disease (ESRD) patients had higher levels of inflammation markers (NLR, IgG, CRP and YKL-40) and lower HCV RNA levels, HAI and FS compared to non-uremic patients. When patients were grouped into 2 according to FS as mild and severe, IgG (p < 0.001), YKL-40 (p = 0.02) levels and APRI score (p = 0.002) were significantly higher compared to mild FS (p = 0.002). YKL-40 levels (t value: 3.48; p = 0.001) and APRI score (t value: 4.57, p < 0.001) were found as independent associated with FS in non-uremic patients. However, in adjusted models, only APRI score (t value: 3.98, p = 0.002) was an independent associated with FS in ESRD patients. CONCLUSION: In non-uremic cHepC patients, YKL-40 levels and APRI score may be valuable markers of FS. In ESRD patients, there is not sufficient data for prediction of HAI and FS. In these patients, APRI score may provide better information.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a biologické markery $x metabolismus $7 D015415
- 650 _2
- $a biopsie $7 D001706
- 650 _2
- $a trombocyty $x metabolismus $7 D001792
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a protein CHI3L1 $x krev $7 D000071451
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a chronická hepatitida C $x patofyziologie $7 D019698
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a zánět $x patofyziologie $7 D007249
- 650 _2
- $a počet leukocytů $7 D007958
- 650 _2
- $a játra $x patologie $7 D008099
- 650 _2
- $a počet lymfocytů $7 D018655
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a neutrofily $x metabolismus $7 D009504
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a uremie $x komplikace $7 D014511
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kose, Sukran $u University of Health Science, Izmir Tepecik Education and Research Hospital, Clinic of Infectious Diseases and Clinical Microbiology, Izmir, Turkey
- 700 1_
- $a Pala, Emel $u University of Health Science, Izmir Tepecik Education and Research Hospital, Pathology, Izmir, Turkey
- 700 1_
- $a Tatar, Erhan $u University of Health Science, Izmir Bozyaka Education and Research Hospital, Department of Nephrology, Izmir, Turkey
- 773 0_
- $w MED00010947 $t Acta Medica (Hradec Kralove) $x 1211-4286 $g Roč. 60, č. 2 (2017), s. 71-75
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28976873 $y Pubmed
- 856 41
- $u https://actamedica.lfhk.cuni.cz/media/pdf/am_2017060020071.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 3077 $c 1072 $y 4 $z 0
- 990 __
- $a 20180611 $b ABA008
- 991 __
- $a 20180619074831 $b ABA008
- 999 __
- $a ok $b bmc $g 1311790 $s 1017955
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 60 $c 2 $d 71-75 $i 1211-4286 $m Acta Medica $n Acta Med. (Hradec Král.) $x MED00010947
- LZP __
- $b NLK118 $a Pubmed-20180611